More on that in a minute
According to NICE CG189, bariatric surgery is recommended for adults with a BMI of 40 kg/m or above, or 35 kg/m and above with a significant obesity-related condition such as type 2 diabetes, when other interventions have not been effective
Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases
#Type2Diabetes #DiabetesCare #GLP1 #Semaglutide #Tirzepatide #SGLT2Inhibitors #Endocrinology #PharmaMarketIntelligence #MarketResearch #DrugDevelopment #Biopharma #CardiometabolicHealth #HealthcareInnovation #PharmaCommercial To view or add a comment, sign in Kailera Therapeutics Therapeutics has reported positive Phase 3 results for oral GLP-1 candidate KAI-7535 in obesity and type 2 diabetes, although high gastrointestinal event rates remain a major commercial and clinical concern.#KaileraTherapeutics #KAI7535 #GLP1 #ObesityTreatment #Type2Diabetes #ClinicalTrials #Biotechnology #WeightLoss #MetabolicDisease #KLRA To view or add a comment, sign in Tsunami of LDL-lowering drugs, yet a high incidence of vascular plaques and heart attacks is still killing people
Liang N, Jiao Z, Zhang C, Wu Y, Wang T, Li S, et al
Nutritional modifications are particularly important given the appetite-suppressing effects of GLP-1 therapy